Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
Neuralink
93 followers
Cytokinetics
21 followers
BridgeBio
14 followers
Travere Therapeutics
6 followers
ElevateBio
6 followers
Avid Bioservices
3 followers
Biodesix
3 followers
Verve Therapeutics
60 followers
HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY
2 followers
AxoGen
1 follower
Cell Signaling Technology
1 follower
J. Craig Venter Institute
1 follower